Synthesis and cytotoxicity studies of novel benzhydrylpiperazine carboxamide and thioamide derivatives

References

• Gao L, Li M, Meng T, et al. Asymmetric synthesis and biological evaluation of N-cyclohexyl-4-[1-(2,4-dichlorophenyl)-1-(p-tolyl)methyl]piperazine-1-carboxamide as hCB1 receptor antagonists. Eur J Med Chem 2011;46:5310–16
   Google Scholar
• Cumming JG, Bower JF, Waterson D, et al. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity. Bioorg Med Chem Lett 2012;22:3895–9
   PubMed Web of Science ®Google Scholar
• Kinoyama I, Taniguchi N, Toyoshima A, et al. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3-yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist. J Med Chem 2006;49:716–26
   PubMed Web of Science ®Google Scholar
• Sun Q, Tafesse L, Islam K, et al. 4-(2-Pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonists. Bioorg Med Chem Lett 2003;13:3611–16
   PubMed Web of Science ®Google Scholar
• Matsuno K, Nakajima T, Ichimura M, et al. Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives. J Med Chem 2002;45:4513–23
   Google Scholar
• Albro LP, Baltzly R, Phillips AP. Unsymmetrically disubstituted piperazines II. Histamine antagonists. J Org Chem 1949;14:771–4
   Google Scholar
• Baltzly R, DuBreuil S, Ide WS, Lorz E. Unsymmetrically disubstituted piperazines III. N-methyl-N′-benzhydrylpiperazines as histamine antagonists. J Org Chem 1949;14:775–82
   Google Scholar
• Iemura R, Kawashima T, Fukuda T, et al. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents. J Med Chem 1986;29:1178–83
   PubMed Web of Science ®Google Scholar
• Beck K, Hamlin K, Weston A. Histamine antagonists. IV. C-methyl derivatives of 1,4-disubstituted piperazines. J Am Chem Soc 1952;74:605–8
   Google Scholar
• Vandenberk J, Kennis L, Van der Aa M, et al. Piperazine derivatives. Janssen Pharmaceutica, US 4250176; February 1981
   Google Scholar
• Wang L, Wang T, Yang B, et al. Design, synthesis, and anti-allergic activities of novel (R)(-)-1-[(4-chlorophenyl)phenylmethyl]piperazine derivatives. Med Chem Res 2010;21:124–32
   Google Scholar
• Zamponi G, Feng Z, Zhang L, et al. Scaffold-based design and synthesis of potent N-type calcium channel blockers. Bioorg Med Chem Lett 2009;19:6467–72
   PubMed Web of Science ®Google Scholar
• Alps B. Drugs acting on calcium channels – potential treatment for ischemic stroke. Brit J Clin Pharmaco 1992;34:199–206
   Google Scholar
• Miyake N, Fujita R, Ishikawa M, et al. Reversal of multidrug resistance in human leukemia K562 by tamolarizine, a novel calcium antagonist. Jpn J Pharmacol 2000;82:265–8
   Google Scholar
• Kimura M, Masuda T, Yamada K, et al. Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities. Bioorg Med Chem Lett 2002;12:1947–50
   Google Scholar
• Pajouhesh H, Feng Z, Ding Y, et al. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors. Bioorg Med Chem Lett 2010;20:1378–83
   Google Scholar
• Kam Y, Rhee H, Rhim H, et al. Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity. Bioorg Med Chem 2010;18:5938–44
   Google Scholar
• Kurokawa M, Sato F, Hatano N, et al. A new class of calcium antagonists. Synthesis and biological activity of 11-[(ω-aminoalkanoyl)amino]-6,6a,7,8,9,10,10a,11-octahydrodibenzo[b,e]thiepin derivatives. J Med Chem 1991;34:593–9
   Google Scholar
• Doddareddy M, Choo H, Cho Y, et al. 3D pharmacophore based virtual screening of T-type calcium channel blockers. Bioorg Med Chem 2007;15:1091–105
   PubMed Web of Science ®Google Scholar
• Sasse B, Mach U, Leppaenen J, et al. Hybrid approach for the design of highly affine and selective dopamine D-3 receptor ligands using privileged scaffolds of biogenic amine GPCR ligands. Bioorg Med Chem 2007;15:7258–73
   PubMed Web of Science ®Google Scholar
• Jung J, Jung S, Koh H. Asymmetric synthesis of chiral piperazinylpropylisoxazoline ligands for dopamine receptors. Eur J Med Chem 2007;42:1044–8
   Google Scholar
• Kimura M, Masuda T, Yamada K, et al. Synthesis of novel diphenyl piperazine derivatives and their activities as inhibitors of dopamine uptake in the central nervous system. Bioorg Med Chem 2003;11:1621–30
   Google Scholar
• Abou-Gharbia M, Patel UR, Moyer JA, Muth EA. Psychotropic agents: synthesis and antipsychotic activity of substituted β-carbinoles. J Med Chem 1987;30:1100–5
   PubMed Web of Science ®Google Scholar
• Okachi R, Niino H, Kitaura K, et al. Synthesis and antibacterial activity of 2,2′-dithiobis(benzamide) derivatives against Mycobacterium species. J Med Chem 1985;28:1772–9
   PubMed Web of Science ®Google Scholar
• Punkvang A, Saparpakorn P, Hannongbua S, et al. Insight into crucial inhibitor-enzyme interaction of arylamides as novel direct inhibitors of the enoyl ACP reductase (InhA) from Mycobacterium tuberculosis: computer-aided molecular design. Monatsh Chem 2010;141:1029–41
   Google Scholar
• Dinakaran M, Senthilkumar P, Yogeeswari P, et al. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxo-benzothiazolo[3,2-a]quinoline-6-carboxylic acid. Bioorg Med Chem 2008;16:3408–18
   PubMed Web of Science ®Google Scholar
• Senthilkumar P, Dinakaran M, Banerjee D, et al. Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. Bioorg Med Chem 2008;16:2558–69
   PubMed Web of Science ®Google Scholar
• Upadhayaya R, Vandavasi J, Kardile R, et al. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents. Eur J Med Chem 2010;45:1854–67
   PubMed Web of Science ®Google Scholar
• Kumar A, Siddiqi MI. Receptor based 3D-QSAR to identify putative binders of Mycobacterium tuberculosis Enoyl acyl carrier protein reductase. J Mol Model 2010;16:877–93
   PubMedGoogle Scholar
• Lu XY, Chen YD, You QD. 3D-QSAR studies of arylcarboxamides with inhibitory activity on InhA using pharmacophore-based alignment. Chem Biol Drug Des 2010;75:195–203
   Google Scholar
• Sriram D, Senthilkumar P, Dinakaran M, et al. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro-6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid. J Med Chem 2007;50:6232–9
   PubMed Web of Science ®Google Scholar
• Senthilkumar P, Dinakaran M, Yogeeswari P, et al. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids. Eur J Med Chem 2009;44:345–58
   PubMed Web of Science ®Google Scholar
• Kumar A, Siddiqi M. CoMFA based de novo design of pyrrolidine carboxamides as inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J Mol Model 2008;14:923–35
   Google Scholar
• Lu X, Chen Y, Jiang Y, You Q. Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur J Med Chem 2009;44:3718–30
   Google Scholar
• Muddassar M, Jang J, Gon H, et al. Identification of novel antitubercular compounds through hybrid virtual screening approach. Bioorg Med Chem 2010;18:6914–21
   Google Scholar
• Chandra J, Sadashiva C, Kavitha C, Rangappa K. Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)methyl]piperazine. Bioorg Med Chem. 2006;14:6621–7
   Google Scholar
• Verderame M. 1,4-Disubstituted piperazines. 3. Piperazinylbenzothiazoles. J Med Chem 1972;15:693–4
   Google Scholar
• Aytemir M, Ozcelik B. A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities. Eur J Med Chem 2010;45:4089–95
   PubMed Web of Science ®Google Scholar
• Patel I, Parmar S. Synthesis and studies of novel optically active Schiff’s base derivatives and their antimicrobial activities. E-J Chem 2010;7:617–23
   Google Scholar
• Srinivasan S, Gupta S, Marwah R, et al. Synthesis, characterization and in vitro biological studies of novel N-aryl piperazinyl fluoroquinolones. Res J Pharm Biol Chem Sci 2010;1:208–18
   Google Scholar
• Shivakumara K, Prakasha K, Gowda D. Synthesis and antimicrobial activity of amino acids conjugated diphenylmethylpiperazine derivatives. E-J Chem 2009;6:473–9
   Google Scholar
• Chern J, Shia K, Hsu T, et al. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidinies: a novel class of potent enterovirus inhibitors. Bioorg Med Chem Lett 2004;14:2519–25
   PubMed Web of Science ®Google Scholar
• Curreli F, Zhang H, Zhang X, et al. Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid. Bioorg Med Chem 2011;19:77–90
   Google Scholar
• Kumar C, Prasad S, Vinaya K, et al. Synthesis and in vitro antiproliferative activity of novel 1-benzhydryl-piperazine derivatives against human cancer cell lines. Eur J Med Chem 2009;44:1223–9
   Google Scholar
• Yarim M, Koksal M, Durmaz I, Atalay R. Cancer cell cytotoxicities of 1-(4-Substitutedbenzoyl)-4-(4-chlorobenzhydryl)piperazine derivatives. Int J Mol Sci 2012;13:8071–85
   PubMed Web of Science ®Google Scholar
• Huang W, Liu M, Li Y, et al. Design, synthesis and antitumor activity of novel chromone and aurone derivatives. Bioorg Med Chem 2007;15:5191–7
   PubMed Web of Science ®Google Scholar
• Huang W, Ding Y, Miao Y, et al. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones. Eur J Med Chem 2009;44:3687–96
   PubMed Web of Science ®Google Scholar
• Gan L, Fang B, Zhou C. Synthesis of azole-containing piperazine derivatives and evaluation of their antibacterial, antifungal and cytotoxic activities. B Kor Chem Soc 2010;31:3684–92
   Web of Science ®Google Scholar
• Kumar C, Swamy S, Thimmegowda N, et al. Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Med Chem Res 2007;16:179–87
   Google Scholar
• Wang W, Xu X, Chen Y, et al. Apoptosis of human Burkitt’s lymphoma cells induced by 2-N,N-diethylaminocarbonyloxymethyl-1-diphenyl-methyl-4-(3,4,5-trimethoxybenzoyl)piperazine hydrochloride (PMS-1077). Arch Pharm Res 2009;32:1727–36
   Google Scholar
• Demma M, Maxwell E, Ramos R, et al. SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53. J Biol Chem 2010;285:198–212
   Google Scholar
• Gurdal EE, Yarim M, Durmaz I, Cetin-Atalay R. Cytotoxic activities of some novel benzhydrylpiperazine derivatives. Arzneimittel-Forsch 2013; Accepted Manuscript
   Google Scholar